-+ 0.00%
-+ 0.00%
-+ 0.00%

ALZAMEND NEURO ANNOUNCES INITIATION DATE OF PHASE II CLINICAL TRIAL OF AL001 FOR TREATMENT OF BIPOLAR DISORDER TO TAKE PLACE AT MASSACHUSETTS GENERAL HOSPITAL

Reuters·03/04/2025 13:10:00

Please log in to view news